Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
67
Frequently Asked Questions
What is Market Cap of Tetraphase Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tetraphase Pharmaceuticals Inc market cap is $15.98M.
What is the 52-week high for Tetraphase Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tetraphase Pharmaceuticals Inc 52 week high is $8.60 as of September 30, 2025.
What is the 52-week low for Tetraphase Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tetraphase Pharmaceuticals Inc 52 week low is $0.56 as of September 30, 2025.
What is Tetraphase Pharmaceuticals Inc stock price today?
Tetraphase Pharmaceuticals Inc stock price today is $2.20.
What was Tetraphase Pharmaceuticals Inc stock price yesterday?
Tetraphase Pharmaceuticals Inc stock price yesterday was $2.28.
What is the PE ratio of Tetraphase Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tetraphase Pharmaceuticals Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Tetraphase Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tetraphase Pharmaceuticals Inc P/B ratio is 0.5817.
What is Tetraphase Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Tetraphase Pharmaceuticals Inc's EBITDA is 0.20.
What is the 50-day moving average of Tetraphase Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tetraphase Pharmaceuticals Inc 50-day moving average is $2.42.
How many employess does Tetraphase Pharmaceuticals Inc has?
